This is a preprint.
The microbiome diversifies N-acyl lipid pools - including short-chain fatty acid-derived compounds
- PMID: 39554097
- PMCID: PMC11565975
- DOI: 10.1101/2024.10.31.621412
The microbiome diversifies N-acyl lipid pools - including short-chain fatty acid-derived compounds
Update in
-
The microbiome diversifies long- to short-chain fatty acid-derived N-acyl lipids.Cell. 2025 Jul 24;188(15):4154-4169.e19. doi: 10.1016/j.cell.2025.05.015. Epub 2025 Jun 10. Cell. 2025. PMID: 40499541 Free PMC article.
Abstract
N-acyl lipids are important mediators of several biological processes including immune function and stress response. To enhance the detection of N-acyl lipids with untargeted mass spectrometry-based metabolomics, we created a reference spectral library retrieving N-acyl lipid patterns from 2,700 public datasets, identifying 851 N-acyl lipids that were detected 356,542 times. 777 are not documented in lipid structural databases, with 18% of these derived from short-chain fatty acids and found in the digestive tract and other organs. Their levels varied with diet, microbial colonization, and in people living with diabetes. We used the library to link microbial N-acyl lipids, including histamine and polyamine conjugates, to HIV status and cognitive impairment. This resource will enhance the annotation of these compounds in future studies to further the understanding of their roles in health and disease and highlight the value of large-scale untargeted metabolomics data for metabolite discovery.
Conflict of interest statement
Declaration of interests: PCD: PCD is an advisor and holds equity in Cybele, BileOmix and Sirenas and a Scientific co-founder, advisor and holds equity to Ometa, Enveda, and Arome with prior approval by UC-San Diego. PCD also consulted for DSM animal health in 2023. MW: MW is a co-founder of Ometa Labs LLC. RK: Rob Knight is a scientific advisory board member, and consultant for BiomeSense, Inc., has equity and receives income. He is a scientific advisory board member and has equity in GenCirq. He is a consultant for DayTwo, and receives income. He has equity in and acts as a consultant for Cybele. He is a co-founder of Biota, Inc., and has equity. He is a cofounder of Micronoma, and has equity and is a scientific advisory board member. The terms of these arrangements have been reviewed and approved by the University of California, San Diego in accordance with its conflict of interest policies.
Figures




References
-
- Chang F.-Y., Siuti P., Laurent S., Williams T., Glassey E., Sailer A.W., Gordon D.B., Hemmerle H., and Voigt C.A. (2021). Gut-inhabiting Clostridia build human GPCR ligands by conjugating neurotransmitters with diet- and human-derived fatty acids. Nat Microbiol 6, 792–805. - PubMed
-
- Mann A., Smoum R., Trembovler V., Alexandrovich A., Breuer A., Mechoulam R., and Shohami E. (2015). Palmitoyl Serine: An Endogenous Neuroprotective Endocannabinoid-Like Entity After Traumatic Brain Injury. J. Neuroimmune Pharmacol. 10, 356–363. - PubMed
-
- Waluk D.P., Vielfort K., Derakhshan S., Aro H., and Hunt M.C. (2013). N-Acyl taurines trigger insulin secretion by increasing calcium flux in pancreatic β-cells. Biochem. Biophys. Res. Commun. 430, 54–59. - PubMed
-
- Aichler M., Borgmann D., Krumsiek J., Buck A., MacDonald P.E., Fox J.E.M., Lyon J., Light P.E., Keipert S., Jastroch M., et al. (2017). N-acyl Taurines and Acylcarnitines Cause an Imbalance in Insulin Synthesis and Secretion Provoking β Cell Dysfunction in Type 2 Diabetes. Cell Metab. 25, 1334–1347.e4. - PubMed
-
- Arul Prakash S., and Kamlekar R.K. (2021). Function and therapeutic potential of N-acyl amino acids. Chem. Phys. Lipids 239, 105114. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources